Advancing research for chronic myelogenous leukaemia through clinical trials aimed at exploring potential treatments and improving patient care.
Chronic Myelogenous Leukemia
Finding Potential Treatment for Chronic Myelogenous Leukemia
Chronic Myelogenous Leukemia (CML) is a type of blood cancer that starts in the bone marrow, where blood cells are made. It happens when a genetic change creates an abnormal gene called BCR-ABL, causing cells to grow uncontrollably. Over time, these cells build up in the blood, leading to symptoms like fatigue, weakness, and frequent infections. While CML can progress slowly, advancements in research and treatment have given patients more options and hope for better outcomes.
The trial was conducted in three phases to test the investigational drug’s safety and efficacy with an aim to to find better treatments for CML.
Current Status
Not Recruiting
Study Count
01
Frequently Asked Questions
What is a clinical trial?
A clinical trial is a research study where new treatments, drugs, or procedures are tested to determine their safety and effectiveness for specific conditions.
Can I withdraw from a clinical trial?
Yes, participants can withdraw at any time for any reason. It’s important to communicate with the study team to ensure a safe transition out of the trial.
Are clinical trials safe?
Clinical trials follow strict safety protocols, and participants are closely monitored by healthcare professionals throughout the study.
Will I be informed of the trial’s results?
Participants are often informed of study results, especially if findings could affect future care or available treatments.
How can I find other clinical trials?
You can ask your healthcare provider, explore research center websites, or visit clinical trial registries to find ongoing studies relevant to your condition.
